Remanded (sent back)
The Board remands the claims for further development, including obtaining additional medical evidence and readjudicating the claims.
The deciding factor: The August 2016, November 2021, December 2023, and August 2024 DBQs are inadequate as they do not reflect that the ameliorative effects of medication were discounted, which is required under Jones v. Shinseki.
- Claimed conditions
- Degenerative arthritis; degenerative disc disease; lumbosacral strain; spinal stenosis; thoracolumbar spine osteoarthritis; lumbar annular fissures at L3/L4, L4/L5, L5/S1, Radiculopathy (sciatic nerve) of the left lower extremity (LLE), Radiculopathy (sciatic nerve) of the right lower extremity (RLE), Peripheral neuropathy of the left upper extremity (LUE)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 3, 2025
- Citation
- 25012469
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.